*We do not supply our products directly to consumers. By selecting the Buy Now button on this page, you will be re-directed to a list of retailers’ websites for purchase. Kindly note that purchase will be subject to stock availability
Promotion of Access to Information Act (PAIA)
The PAIA manual is prepared in accordance with section 51 of the Promotion of Access to Information Act (PAIA) No. 2 of 2000 (as amended) and the Protection of Personal Information Act, 2013. The purpose of PAIA is to promote the right of access to information, to foster a culture of transparency and accountability within the Company by giving the right to information that is required for the exercise or protection of any right and to actively promote a society in which the people of South Africa have effective access to information to enable them to exercise and protect their rights.
Applicant: GlaxoSmithKline Consumer Healthcare SA (Pty) Ltd, Company Reg. No. 2014/173930/07. Hawkins Avenue, Epping Industria 1, 7460. Tel. No. +27 0800 118 274.
S0 20 g & 50 g S1 100 g Voltaren Emulgel. Each 100 g contains 1.16 g diclofenac diethylammonium corresponding to 1 g diclofenac sodium Reg. no.: U/3.1/77. Botswana: S3 Reg. no.: B9305535. Namibia: NS1 Reg. no.04/3.1/0344 indicated for use in adults and adolescents older than 12 years. For any product safety issues please contact GSK on 011 745 6001 or 0800 118 274.
Consumer safety is always of the highest priority in GSK Consumer Health. Reports relating to safety are investigated and reported to the authorities by GSK as appropriate. Always use this product in accordance with the labelled instructions. To report an adverse event or complaint, please contact GSK on firstname.lastname@example.org, email@example.com
For full prescribing information refer to the professional information approved by the medicines regulatory authority.